Cannabis Bioscience International Holdings (CBIH) Change in Receivables (2023 - 2026)
Cannabis Bioscience International Holdings' (CBIH) quarterly Change in Receivables came in at -$20545.0 in Q1 2026, down 83.78% year-on-year from -$126680.9 in Q1 2025, and down 259.95% quarter-over-quarter from $12845.0 in Q4 2025.
Cannabis Bioscience International Holdings (CBIH) Change in Receivables (2023 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed Change in Receivables across 4 years of filings, most recently posting -$20545.0 for Q1 2026.
- Change in Receivables for Q1 2026 came in at -$20545.0, down 83.78% year-over-year; the trailing twelve-month figure through Feb 2026 was $21540.0 (up 249.56% YoY), and the FY2025 annual result was $9155.0, down 10.14% from the prior year.
- Change in Receivables came in at -$20545.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from $12845.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $26654.0 in Q2 2025 to a low of -$28765.0 in Q1 2023.
- The 4-year median for Change in Receivables is -$1763.0 (2024), against an average of -$651.62.
- Peak annual rise in Change in Receivables reached 760.64% in 2025, while the deepest fall reached 534.09% in 2025.
- Cannabis Bioscience International Holdings' Change in Receivables stood at -$8590.0 in 2023, then jumped by 60.92% to -$3357.0 in 2024, then soared by 482.63% to $12845.0 in 2025, then plunged by 259.95% to -$20545.0 in 2026.
- The last three Change in Receivables figures came in at -$20545.0 (Q1 2026), $12845.0 (Q4 2025), and $2586.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 | -20,545.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -20,545.00 |
| Feb 28, 2026 | -20,545.00 |
| Nov 30, 2025 | 12,845.00 |
| Nov 30, 2025 | 12,845.00 |
| Aug 31, 2025 | 2,586.00 |
| Aug 31, 2025 | 2,586.00 |
| May 31, 2025 | 26,654.00 |
| May 31, 2025 | 26,654.00 |
| Feb 28, 2025 | -11,179.00 |
| Feb 28, 2025 | -11,179.00 |
| Nov 30, 2024 | -3,357.00 |
| Nov 30, 2024 | -3,357.00 |
| Aug 31, 2024 | -2,963.00 |
| Aug 31, 2024 | -2,963.00 |
| May 31, 2024 | 3,097.00 |
| May 31, 2024 | 3,097.00 |
| Feb 29, 2024 | -1,763.00 |
| Feb 29, 2024 | -1,763.00 |
| Nov 30, 2023 | -8,590.00 |
| Nov 30, 2023 | -8,590.00 |